期刊文献+

药物复律治疗心房扑动的临床效果分析

原文传递
导出
摘要 目的探讨药物复律治疗心房扑动的临床效果。方法选取2015年1月—2015年10月在永煤集团总医院治疗的心房扑动患者56例,随机分为两组各28例,观察组应用伊布利特治疗,对照组给予普罗帕酮治疗,对比两组转复时间、转复率及不良反应。结果观察组转复时间、转复率优于对照组(P<0.05);观察组低血压发生率低于对照组(P<0.05);两组其他不良反应无明显差异(P>0.05)。结论药物复律是治疗心房扑动的有效方法,伊布利特治疗效果优于普罗帕酮。
作者 郑艳
出处 《医药论坛杂志》 2016年第7期166-167,共2页 Journal of Medical Forum
  • 相关文献

参考文献3

二级参考文献22

  • 1张海澄,郭继鸿,方全,郑亚安,孙跃民,朱文青,万征,郭静萱,葛均波,韩少梅.静脉注射伊布利特与普罗帕酮转复心房颤动和扑动的多中心研究[J].中华医学杂志,2005,85(12):798-801. 被引量:43
  • 2Kafkas NV, Patsilinakos SP, Mertzanos GA, et al. Conver- sion efficacy of intravenous ibutilide compared with intra- venous amiodarone in patients with recent-onset atrial fib- rillation and atrial flutter[J]. Int J Cardiol, 2007, 118(3): 321-325.
  • 3Gowda RM, Punukollu G, Khan IA, et al. Ibutilide for pharmacological cardioversion of atrial fibrillation and flut- ter:impact of race on eficaey and safety[J]. Am J Ther, 2003, 10(4):259-263.
  • 4Letelier LM, Udol K, Ena J, et al. Effectiveness of amio- darone for conversion of atrial fibrillation to sinus rhythm:a meta-analysis[J]. Arch Intern Med, 2003, 163(7):777-785.
  • 5Oshikawa N, Watanabe I, Masaki R, et al. Frequency-de- pendent electrophysiological effect of ibutilide on human atrium and ventricle[J]. J Interv Card Electrophysiol, 2001, 5(1):81-87.
  • 6Wood MA, Gilligan DM, Brown-Mahoney C, et al. Clinical and electrophysiologic effects of Calcium Channel blockers in patients receiving ibutilide[J]. Am Heart J, 2002, 143(1): 176-180.
  • 7Fuster V, Ryd6n LE, Cannom DS, et al. 2011 ACCF/AHA/ HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation:a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J]. J Am Coll Cardiol, 2011, 123(10): e269-e367.
  • 8Fuster V,Ryden LE,Cannom DS. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration wi[J].Europace:European Pacing,Arrhythmias and Cardiac Electrophysiology,2006.651-745.
  • 9Cropp JS,Antal EG,Talbert RL. Ibutilide:a new class Ⅲ antiarrhythmic agent[J].Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy,1997.1-9.
  • 10Mountantonakis SE,Moutzouris DA,Tiu RV. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter[J].American Journal of Emergency Medicine,2006.407-412.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部